Information  X 
Enter a valid email address

SkinBioTherapPLC Ord 1P (SBTX)

Related News

29-Mar-2022 02:39 PM

IN BRIEF: SkinBioTherapeutics loss widens as underperforms in US

SkinBioTherapeutics PLC- Skin health-focused life sciences company - Says pretax loss widens to £1.2 million in six months to December 31, from £628,241 a year earlier. US market penetration with its only product launched in October 2021, Axi
28-Mar-2022 10:57 AM

SkinBioTherapeutics proposes Manprit Singh Randhawa as new CFO

SkinBioTherapeutics PLC on Monday said it has proposed to appoint Manprit Singh Randhawa as its new chief financial officer. The skin health-focused life sciences company said Randhawa will replace current part-time CFO Doug Quinn upon nominat
17-Feb-2022 11:13 AM

SkinBioTherapeutics expects GBP1.2 million sales for psoriasis product

(Alliance News) - SkinBioTherapeutics PLC shares were down on Thursday, after soaring in recent days, as it gave an update on its skincare portfolio. Following a "soft launch" of its AxisBiotix-Ps supplement for psoriasis, the
08-Apr-2021 09:02 AM

SkinBioTherapeutics launces skin health research programme with University of Manchester

Skin health company SkinBioTherapeutics is to launch a research programme with the University of Manchester to investigate and develop microbiome formulations that support natural anti-inflammatory response to a range of environmental challenges. Expand
15-Mar-2021 07:49 AM

SkinBioTherapeutics posts first-half loss on R&D, operating costs

Skin-health focused SkinBioTherapeutics posted a first-half loss as it continued to shell out on R&D and other operating costs. Pre-tax losses for the six months through December amounted to £0.63 million, compared to losses of £0.89 million
03-Mar-2020 09:33 AM

SkinBioTherapeutics books loss after upping R&D spend

Skin health focused SkinBioTherapeutics booked a first-half loss as it upped spending on R&D. Pre-tax losses for the six months through December amounted to £0.89m, compared to losses of £0.63m on-year. 'The first half of the year has b
26-Nov-2019 08:07 AM

SkinBioTherapeutics books annual loss on higher R&D spend

Skin health focused SkinBioTherapeutics booked a full-year loss amid a rise in R&D and operating expenses. Pre-tax losses for the year through June amounted to £1.36m, compared to losses of £0.94m on-year. The company had cash at the end of
01-Aug-2018 12:45 PM

SkinBioTherapeutics to present on 12 September 2018 at the Shares and AJ Bell Spotlight Evening in E

Come and join Shares and AJ Bell Media at their Edinburgh investor evening on Wednesday 12 September 2018 at the Radisson Blu Hotel, located in the heart of the historic Royal Mile. The Edinburgh investor evening event provides an opportunity for Board
29-May-2018 12:24 PM

SkinBioTherapeutics to present on 20 June 2018 at the Shares and AJ Bell Spotlight Evening in London

Come along to the Shares and AJ Bell Investor Evening in London on 20 June 2018 and listen to and meet Directors of listed companies. The event gives you the chance to come along and meet the key people at companies you might like to invest in. That cou
23-Jan-2018 11:02 AM

SkinBioTherapeutics to present on 28 February 2018 at the Shares and AJ Bell Spotlight Evening in Ed

If you are looking for some new investment ideas for 2018, then come along to the Shares and AJ Bell Investor Evening in Edinburgh on Wednesday 28 February 2018. Directors from London Stock Exchange listed companies will present their latest plans regardi
23-Jan-2018 09:38 AM

SkinBioTherapeutics to present on 20 February 2018 at the Shares and AJ Bell Spotlight Evening in Ma

If you are looking for some new investment ideas for 2018, then come along to the Shares and AJ Bell Investor Evening in Manchester on Tuesday 20 February 2018. Directors from London Stock Exchange listed companies will present their latest plans regardin
09-Nov-2017 08:54 AM

SkinBiotix passes external toxicity tests

SkinBioTherapeutics, a life science company focused on skin health, has passed two additional and final third party cellular toxicity tests for its SkinBiotix technology. The in vitro tests, for photo-toxicity (sensitivity to sunlight) and ocular toxicit
30-Oct-2017 01:21 PM

SkinBioTherapeutics resolutions passed at AGM

SkinBioTherapeutics has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 1:21pm: (LON:SBTX) SkinBioTherapeutics Plc share price was 0p at 10.75p Story provided by StockMarketWire.com...
05-Oct-2017 07:10 AM

SkinBioTherapeutics loss deepens

SkinBioTherapeutics posted a deeper annual loss after it continued to invest in the development of potential skin treatments. The company booked a net loss of £645,554, deepening from a £4,201 loss in the previous year. At June 30, SkinBioTh

a d v e r t i s e m e n t